Page last updated: 2024-09-02

arginyl-glycyl-aspartyl-serine and Hyperplasia

arginyl-glycyl-aspartyl-serine has been researched along with Hyperplasia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, HW; Peng, S; Wang, C; Xiong, Y; Zhao, M1
Hiragun, T; Kameyoshi, Y; Kanno, M; Morita, E; Okabe, T; Shindo, H; Tanaka, T; Yamamoto, S1

Other Studies

2 other study(ies) available for arginyl-glycyl-aspartyl-serine and Hyperplasia

ArticleYear
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
    Journal of medicinal chemistry, 2007, Jul-12, Volume: 50, Issue:14

    Topics: Alkaline Phosphatase; Animals; Calcium; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Hyperplasia; Mice; Oligopeptides; Organ Size; Osteoporosis; Ovariectomy

2007
Altered in vitro apoptosis of cultured mast cells prepared from an inbred strain of mice, NC/Kuj.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2000, Volume: 30, Issue:3

    Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Adhesion; Cell Survival; Cells, Cultured; Dermatitis; Histamine; Histamine Release; Hyperplasia; Male; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Oligopeptides; Skin

2000